



Cagrilintide is a novel long-acting acylated amylin analogue peptides.
Cagrilintide is an investigational, long-acting synthetic amylin analogue developed by Novo Nordisk for chronic weight management and the treatment of type 2 diabetes. As a dual amylin and calcitocin receptor agonist (DACRA) , it targets a metabolic pathway distinct from traditional GLP-1 medications (like semaglutide) to regulate appetite and energy balance.
If you have interest in various kinds of peptides , pls contact us .
Interested in this product? Reach us via the contact details below.
Peptides High Purity 99% Cagrilintide from Direct Manufacturer Good Price
Cagrilintide is a novel long-acting acylated amylin analogue that acts as a non-selective agonist of the amylin receptor (AMYR) and the calcitonin G protein-coupled receptor (CTR). Cagrilintide significantly reduces body weight and food intake.
Note: For research use only